·All components are fully defined, serum-free, protein-free and DMSO-free. Toxicity test and long-term storage test have been completed. ·Compound cryoprotectants are adopted to significantly reduce cryopreservation damage to cells and greatly improve cell recovery rate and viability. ·With documented IND/filing cases, Yocon can provide guidance for customers on the cryopreservation medium section during cell therapy product filing.

For cryopreservation of mesenchymal stem cells and other cell therapy products, suitable for preclinical research, IIT and IND development.